The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Previously Treated Advanced Thymic Epithelia Tumors: A Retrospective Analysis

BACKGROUND: Thymic epithelial tumors (TETs) are rare thoracic malignancies with no standard second-line treatment. Tumor angiogenesis is closely associated with the pathogenesis and invasiveness of TETs. Anlotinib is a small-molecule multitarget tyrosine kinase inhibitor (TKI) which inhibits tumor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuo, Zhou, Haiyan, Zhang, Xiqin, Bu, Bing, Tao, Rongjie, Zhang, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Medicine, Oncology, Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230606/
https://www.ncbi.nlm.nih.gov/pubmed/36415100
http://dx.doi.org/10.2174/1574892818666221122114753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230606/
https://www.ncbi.nlm.nih.gov/pubmed/36415100
http://dx.doi.org/10.2174/1574892818666221122114753

Ejemplares similares